Ken Griffin Royalty Pharma PLC Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 237,700 shares of RPRX stock, worth $8.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

237,700

Previous 104,100 128.34%

Holding current value

$8.21 Million

Previous $2.66 Million 178.68%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$25.75 - $33.86 $21.4 Million - $28.2 Million	-832,188 Reduced 28.72%	2,065,776 $64.3 Million
Q4 2024 Feb 14, 2025	BUY	$24.28 - $28.39 $70.4 Million - $82.3 Million	2,897,964 New	2,897,964 $73.9 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $10.7 Million - $12.2 Million	-389,101 Reduced 79.89%	97,919 $2.97 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $9.54 Million - $10.6 Million	363,939 Added 295.69%	487,020 $13.7 Million
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $14 Million - $16.7 Million	-532,291 Reduced 81.22%	123,081 $3.34 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $12.5 Million - $15.5 Million	-423,582 Reduced 39.26%	655,372 $20.1 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $18.6 Million - $22.3 Million	567,014 Added 110.76%	1,078,954 $38.9 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $6.89 Million - $7.75 Million	175,979 Added 52.38%	511,940 $20.2 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $3.04 Million - $3.4 Million	76,116 Added 29.29%	335,961 $13.5 Million
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $49.7 Million - $58.5 Million	-1,323,288 Reduced 83.59%	259,845 $10.9 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $51.4 Million - $58.2 Million	1,371,252 Added 647.18%	1,583,133 $61.7 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $3.51 Million - $4.24 Million	99,702 Added 88.88%	211,881 $8.44 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $13.6 Million - $15.9 Million	-377,172 Reduced 77.08%	112,179 $4.05 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $14 Million - $16.4 Million	351,746 Added 255.62%	489,351 $20.1 Million
Q1 2021 May 17, 2021	SELL	$42.34 - $52.82 $7.9 Million - $9.86 Million	-186,636 Reduced 57.56%	137,605 $6 Million
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $9.27 Million - $12.8 Million	256,692 Added 380.01%	324,241 $16.2 Million
Q3 2020 Nov 16, 2020	SELL	$38.56 - $48.36 $33 Million - $41.4 Million	-856,056 Reduced 92.69%	67,549 $2.84 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $41.1 Million - $48.1 Million	923,605 New	923,605 $44.8 Million

Others Institutions Holding RPRX

# of Institutions

484

Shares Held

283M

Call Options Held

2.51M

Put Options Held

941K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account